Navigation Links
Reportlinker Adds The Global Pharmaceutical Fine Chemicals Market Outlook to 2015

NEW YORK, May 30, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

The Global Pharmaceutical Fine Chemicals Market Outlook to 2015


This report provides a comprehensive overview of the global pharmaceutical fine chemicals market including the classification of PFCs, demand/supply dynamics, and the key deals and alliances in the PFC market. The report also analyzes the global PFC industry in terms of market dynamics (market size, drivers and resistors of growth), key merger and acquisitions and recent trends in the industry.

Features and benefits

* Evaluate the PFC market in terms of regulatory environment, demand/supply dynamics, market size and structure.

* Gain up-to-date information regarding the deals and alliances in the PFC industry and how they affect the major players in this market.

* Understand the basic PFC manufacturing processes and the raw materials used in their production.

* Understand how recent trends in the pharmaceutical market are responsible for shaping the trends in the PFC industry.

* Analyze the performance of the leading PFC players and gain an insight into their geographic reach, business segments, revenues, growth strategies.


Pharmaceutical fine chemicals are chemicals used in the manufacture of pharmaceutical products. The pharmaceutical industry being one of the largest clients of PFC industry, not only affects the sales dynamics of the PFC industry, but also catalyses certain trends in this industry.

The relative importance of India and China as manufacturing areas for fine chemicals and pharmaceutical APIs has increased over recent decades because of the cost benefits that these countries offer to the pharmaceutical companies.

The drive towards cost reduction in the pharmaceutical industry will continue to create pricing pressure on the fine chemicals industry. Moreover, the consolidation of the pharmaceutical sector will also reduce the number of potential customers for the PFC industry.

Your Key questions answered

* What is the market size and growth rate of the global pharmaceutical fine chemicals market?

* What are the main trends driving the growth of the global PFC market and how is the 'patent cliff' impacting PFC sales?

* Which are the key deals and alliances in the global PFC industry and how will they impact the stakeholders?

* Which are the leading players in the global PFC market and what are their growth strategies?

* What are the key technological developments in the global PFC market?

Table of Contents

About Business Insights 2

Disclaimer 2

Executive summary 9

Industry overview 9

Market overview 10

Recent trends in the pharmaceutical fine chemicals industry 11

Competitive landscape 11

Scope and methodology 13

Scope 13

Methodology 13

Chapter 1 Industry overview 15

Summary 15

Introduction 16

Classification of pharmaceutical fine chemicals (PFCs) 17

Basic intermediates 18

Key intermediates 19

Active pharmaceutical ingredients 19

Demand for pharmaceutical fine chemicals 20

Supply of pharmaceutical fine chemicals 21

Production of pharmaceutical fine chemicals 23

Raw materials used for the production of PFCs 23

Manufacturing procedures 24

Current regulatory environment for pharmaceutical intermediates 25

GMP requirements 25

ICH Q7A 25

US GMP – Federal Food Drug and Cosmetic Act 26


China GMP – GMP for pharmaceutical products 28

India GMP – Drugs and cosmetics rules Schedule M 29

Drug Price Competition and Patent Term Restoration Act ('Hatch-Waxman Act') 29


Key deals and alliances in the global pharmaceutical fine chemicals market 31

Chapter 2 Market overview 33

Summary 33

Introduction 34

Market dynamics 35

Global market size and structure 35

Regional distribution 37

Future outlook of the global PFC market 38

Drivers and resistors of PFC industry 41

Drivers of the PFC industry 42

Resistors of the PFC industry 44

Chapter 3 Recent trends in the pharmaceutical fine chemicals industry 46

Summary 46

Introduction 47

Increasing pricing pressure on PFC companies 48

Downturn in the innovative API market; upturn in the generic API market 48

Increasing PFC outsourcing is creating new growth opportunities 51

Recent innovations in the PFC manufacturing processes 52

Small molecule production technologies 52

Biotechnological manufacturing methods 55


Antibody-drug conjugates 57

Relocation to emerging and fast growing markets 57

Chapter 4 Competitive landscape 59

Summary 59

Introduction 60

Competitive landscape 60

Capability analysis 61

Albemarle Corporation 62

Company overview 62

Business segmentation 62

Financial performance 63

Growth strategy 63


Company overview 64

Business segmentation 64

Financial performance 66

Growth strategy 66

Boehringer Ingelheim 67

Company overview 67

Business segmentation 68

Financial performance 68

Growth strategy 69

Cambrex 69

Company overview 69

Business segmentation 69

Financial performance 70

Growth strategy 70

DSM 71

Company overview 71

Business segmentation 72

Financial performance 73

Growth strategy 74

Evonik 76

Company overview 76

Business segmentation 76

Financial performance 76

Growth strategy 78

Lonza 79

Company overview 79

Business segmentation 79

Financial performance 80

Growth strategy 81

Novasep 83

Company overview 83

Business segmentation 83

Financial performance 84

Growth strategy 84

Sigma-Aldrich 84

Company overview 84

Business segmentation 84

Financial performance 85

Growth strategy 85

Sumitomo Chemical 86

Company overview 86

Business segmentation 87

Financial performance 88

Growth strategy 88

Other major PFC companies 89

Archimica 89

Daiichi Fine Chemical 90

KemFine 90

Saltigo 91

Siegfried 92

Abbreviations 93

Table of figures

Figure 2: Classification of chemicals based on functionality and industrial applications 18

Figure 3: Supply chain of pharmaceutical fine chemicals 22

Figure 3: Relationship between the industries involved in the PFC market 34

Figure 4: Supply areas of pharmaceutical intermediates in 2009 38

Figure 5: Supply areas of Pharmaceutical intermediates in 2015 39

Figure 6: Drivers and resistors of pharmaceutical fine chemical industry 41

Figure 7: Pharmaceutical industry trends influencing the PFC industry 48

Figure 8: Effect of patent cliff on the API market 49

Figure 9: Capability analysis of the leading 10 PFC companies 61

Figure 10: Albemarle's fine chemicals division net sales 63

Figure 11: Cambrex's fine chemicals sales ($m), 2010 70

Figure 12: DSM's pharmaceutical division net sales ($m), 2010 74

Figure 13: Evonik's chemical division net sales ($m), 2010 78

Table of tables

Table 1: Differentiating characteristics of commodities, fine chemicals and specialty chemicals 17

Table 2: List of important basic pharmaceutical intermediates and their applications 19

Table 3: List of major natural sources used in the synthesis of APIs 23

Table 4: List of major petrochemical products used in the synthesis of APIs 23

Table 5: Global pharmaceutical market by country ($m), 2009 36

Table 6: Forecast sales performance of pharmaceutical fine chemicals, 2010–2015 39

Table 7: Patent expiries of key pharmaceutical compounds during 2010–2015 50

Table 8: Performance of leading PFC companies ($m), 2009 60

Table 9: BASF financial performance by segment ($m), 2009 66

Table 10: Boehringer Ingelheim financial performance by segment ($m), 2009 68

Table 11: DSM financial performance by segment ($m), 2009 73

Table 12: Evonik's Chemical division sales ($m), 2009 77

Table 13: Lonza financial performance ($m), 2009 80

To order this report:

Chemical and Material Industry: The Global Pharmaceutical Fine Chemicals Market Outlook to 2015

Chemical and Material Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact Nicolas Bombourg
US: (805)652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
(Date:10/9/2015)... -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX ) today announced ... Society of Emergency Medicine (EuSEM) meeting to be held October ... the Lingotto Congress Centre in Turin, Italy ... medicine practitioners in the world with over 2000 delegates in ... previously announced phase 2 bunionectomy trial will also be included.  ...
(Date:10/9/2015)... October 9, 2015 El ,JCA-Mauvernay Award 2015, ... y Junko Takita    --> ... los doctores Yutaka Kondo y ... Award 2015, se ha otorgado a los doctores ... ™ , una compañía biofarmacéutica global con sede enSuiza, presentará el ...
(Date:10/8/2015)... , Oct. 8, 2015  Ardelyx, Inc. ... focused on gastrointestinal and cardio-renal diseases, today announced ... candidate, tenapanor, will be presented at the 2015 ... findings will include measures of sustained response in ... blind, placebo-controlled, randomized Phase 2 trial. The meeting ...
Breaking Medicine Technology:
... ,, NEW YORK , Aug. 3 ITelagen, a ... it was selected by Manhattan ,s Physician Group (MPG) to host, ... includes hosting of patient data in ITelagen,s SAS-70 Type II certified datacenter ... for staff members. , , ...
... PHILADELPHIA , Aug. 3 ... a safe, isotope-free alternative to traditional radiation therapy ... focus of 14 clinical research studies presented at ... Meeting.  According to Xoft, Inc., the clinical benefits ...
Cached Medicine Technology:
(Date:10/9/2015)... Beach, CA (PRWEB) , ... October 09, 2015 ... ... is now offering a special promotion on Invisalign, the orthodontic system that uses ... reasons. The aligners are almost invisible against the teeth, which allow patients to ...
(Date:10/9/2015)... , ... October 09, 2015 , ... ... has announced the final product specifications for TRACTUS, the world’s first sterile field ... the United States in response to the FDA’s recent Unique Device Identifier (UDI) ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... The Asthma ... the US Centers for Disease Control and Prevention (CDC) to improve the knowledge and ... that AAFA has been awarded a project by the CDC and allows AAFA to ...
(Date:10/9/2015)... Orleans, LA (PRWEB) , ... October 09, 2015 ... ... with offices serving New Orleans and the surrounding communities, is initiating a combined ... and medical care for unwanted animals in southern Louisiana. , Animal Rescue ...
(Date:10/9/2015)... ... October 09, 2015 , ... Prescription Hope, the ... walks of life to save money on the high cost of their prescription ... per medication, individuals and families can receive their medications delivered direct from over ...
Breaking Medicine News(10 mins):
... Medicine, Radiation Therapy after Lumpectomy// and five years of treatment ... both cancer recurrence and new tumors in older women with ... standard care for younger patients, it is has been shown ... lead author Ann M. Geiger, M.P.H., Ph.D., an associate professor ...
... found that endurance athletes with ventricular arrhythmias also possess ... in endurance sports come up with a relatively rare ... arrhythmia, the heart beats at an abnormal rate and ... majority of athletes with VA also have worthless right ...
... beneficial traits shape up in natural populations,// but one is ... traits. Two theories have tried to address this challenge – ... ,The theory of hitchhiking has indicated that ... frequent in natural populations when they "hitch a ride" with ...
... right kind of diet is said to have a beneficial effect ... promote good health in men are the following // ,Vegetables ... health boosters while the non-vegetarian food like oysters, shrimps and deep ... aid in the digestion of proteins and nutrients and also help ...
... twenties group who take the preventive test for cervical cancer viz. ... in 2005-06 from 80% in 1995. A parallel trend was observed ... said to avoid this test due to the painful and invasive ... the young women population who are avoiding this test are the ...
... states that fat men are able to handle heart attacks ... team of researchers from University of California. ... heart attacks, they were able to recuperate better than thin ... of fat reserves in their body which is helping them ...
Cached Medicine News:
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
... RNA, Or Fluorescent Tags. Accurate quantitation of minute ... life science research. The RF-Mini 150 Fluorometer offers ... small as 1ng/ml of DNA specific Hoechst Dye. ... emission filters, the RF-Mini 150 can measure RNA ...
Medicine Products: